Using revenue model with the average price-to-sale ratio of 3.35 for firms in healthcare product industry.
(reference: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html )
The current revenue for 2015 is $33millions, with growth over 10 percent on the basis of half-year result.
The market cap from the revenue model is about $115.5 millions, => share price about $0.69
The potential for CMP is much larger, due to massive investment into R&D and eHealth.
eHealth has already secured $10millions dollar order in China.
The initial revenue once eHealth launched, already exceeded 40millions. With improving margin and weak AUD.
If CMP can grow 10% in revenue each year. In 2020, revenue is about 64millions. => market cap of $214millions (SP of $1.2)
If CMP can grow 20% in revenue each year. In 2020, revenue is about 100millions => market cap of $335 millions.(SP of $2)
Using revenue model with the average price-to-sale ratio of 3.35...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.78M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7090 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 10.46am 16/09/2025 (20 minute delay) ? |
| CMP (ASX) Chart |
Day chart unavailable